Introduction: Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapy for the treatment of refractory hematopoietic malignancies. Adverse events are common. and neurotoxicity is one of the most important. However. https://icemanvideoesgames.shop/product-category/ds/